Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

163.57
+1.721.06%
Volume:1.88M
Turnover:306.97M
Market Cap:253.70B
PE:24.49
High:165.42
Open:164.21
Low:162.58
Close:161.85
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.10
T/O Rate:0.13%
Dividend:3.17
Dividend Rate:1.94%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:5.04
PE(LYR):25.01

Loading ...

AstraZeneca PLC Stock Falls Wednesday, Underperforms Market

Dow Jones
·
1 hour ago

The 'CIA' Strategy Beating the Market: How One Top-Performing Money Manager Spots Mispriced Stocks.

Dow Jones
·
Yesterday

AstraZeneca's Long-Term Outlook Could Look Safer After Next Year

Dow Jones
·
Yesterday

AstraZeneca Can Meet 2030 Target Even if Lung-Cancer Trial Fails

Dow Jones
·
Yesterday

UBS Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Yesterday

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live
·
Yesterday

AstraZeneca price target lowered to 150 GBp from 160 GBp at Berenberg

TIPRANKS
·
Yesterday

Berenberg Trims Price Target on AstraZeneca to $203 From $214, Keeps Buy Rating

MT Newswires Live
·
Sep 15

AstraZeneca's Portfolio Diversity Bodes Well

Dow Jones
·
Sep 15

AstraZeneca (AZN) was upgraded to a Hold Rating at Deutsche Bank

TIPRANKS
·
Sep 15

Berenberg Bank Remains a Buy on AstraZeneca (AZN)

TIPRANKS
·
Sep 15

RBC Capital Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 15

Top Midday Decliners

MT Newswires Live
·
Sep 15

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 15

AstraZeneca Can Overcome Recent Trial Setbacks

Dow Jones
·
Sep 14

Dow Jones Top Company Headlines at 11 am ET: Microsoft Sets Limits for AI Models as Altman Details Control Risks | Dell's ...

Dow Jones
·
Sep 14

AstraZeneca, Daiichi Drug Has Good Lung-Cancer Data, but Competition Awaits

Dow Jones
·
Sep 14

Sector Update: Healthcare Stocks Rise Premarket Monday

MT Newswires Live
·
Sep 14

AstraZeneca reports results from DESTINY-Lung04 trial

TIPRANKS
·
Sep 14

AstraZeneca reports updated exploratory results from ADAURA trial

TIPRANKS
·
Sep 14